Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
The Most Exciting Market for Lilly's Diabetes Drug May Be Something Else
12:20pm, Saturday, 14'th May 2022
The Food and Drug Administration approved a new diabetes treatment from Eli Lilly on Friday.
Got $10,000? These 3 Growth Stocks Also Pay Dividends
10:53am, Thursday, 12'th May 2022
These stocks can make the most of your money.
Lilly's (LLY) Olumiant Gets Full Approval From FDA for COVID
09:47am, Thursday, 12'th May 2022
The FDA grants full approval to Lilly (LLY) and Incyte for COVID-19 in certain hospitalized adults. Olumiant is already authorized for emergency use for this indication since November 2020.
FDA approves Eli Lilly and Incyte's Olumiant for treatment of certain hospitalized adults with COVID-19
07:04am, Wednesday, 11'th May 2022
Eli Lilly & Co. LLY, -1.22% and Incyte INCY, +4.80% said Wednesday the Food and Drug Administration has approved the use of their Olumiant for the treatment of certain adults who are hospitalized with
Here's My Top Pharma Stock to Buy in May
10:15am, Friday, 06'th May 2022
This company has been flying high over the past 12 months.
Morgan Stanley issues its list of the 45 highest conviction stock picks; Here's our top 3
05:47am, Wednesday, 04'th May 2022
On April 29, American investment bank and financial services company, Morgan Stanley (NYSE: MS) issued a list of top analyst.
Called to Account: Drug companies are making an accounting change after the SEC cracked down on Biogen
03:04pm, Tuesday, 03'rd May 2022
Reporters and analysts covering first-quarter earnings from drug companies may have noticed a change in how they account for upfront payments made to finance research and development at companies in w
Eli Lilly And Company (LLY) Signs $670 Million Deal With Genesis Therapeutics
02:48pm, Tuesday, 03'rd May 2022
Genesis Therapeutics and Eli Lilly And Company (NYSE: LLY) have signed a $670 million deal. These are the details.
Jim Cramer breaks down shares of Estee Lauder, Clorox, Eli Lilly and more
11:30am, Tuesday, 03'rd May 2022
'Mad Money' host Jim Cramer and the 'Squawk on the Street' team discuss shares of Estee Lauder, Chegg, Clorox, HCA Holdings and more following the opening bell on Tuesday.
Analyst Says Eli Lilly Is One of the Strongest Pharma Expansion Stories
05:08pm, Monday, 02'nd May 2022
To use a baseball analogy, Eli Lilly and Co. ( LLY , Financial) hit it out of the park in the first quarter. The Indianapolis-based Big Pharma company put big numbers on the scoreboard in the first th
Top Pharmaceutical Stocks To Watch In May 2022
09:45am, Saturday, 30'th Apr 2022
Check out these pharmaceutical stocks in the stock market today.
Biopharma can perform well in recession based on past data, says Wells Fargo's Mohit Bansal
03:22pm, Friday, 29'th Apr 2022
Mohit Bansal, Wells Fargo Securities senior equity analyst, joins 'Power Lunch' to discuss biopharma and the market.
Lilly's experimental weight-loss drug may be a ‘multibillion-dollar opportunity'
12:17pm, Friday, 29'th Apr 2022
Eli Lilly & Co. Inc.'s LLY, -1.46% promising new weight-loss drug is taking aim at a sector that's littered with once-promising therapies that have failed to deliver on their promise to help people lo
Jim Cramer reacts to Roku, Eli Lilly, Tesla, and more
11:38am, Friday, 29'th Apr 2022
CNBC's Jim Cramer and the ‘Squawk on the Street' team break down shares of Roku, Eli Lilly, Tesla and more following a slew of earnings report from Big Tech companies.
Eli Lilly and Company's (LLY) CEO Dave Ricks on Q1 2022 Results - Earnings Call Transcript
04:21pm, Thursday, 28'th Apr 2022
Eli Lilly and Company (NYSE:LLY ) Q1 2022 Earnings Conference Call April 28, 2022 9:00 AM ET Company Participants Kevin Hern - Vice President, Investor Relations Dave Ricks - Chair and CEO Anat Ashken
